Innate Pharma S.A. (EPA:IPH)
France flag France · Delayed Price · Currency is EUR
2.010
-0.035 (-1.71%)
May 12, 2025, 5:35 PM CET

Innate Pharma Market Cap

Innate Pharma has a market cap or net worth of €185.24 million as of May 12, 2025. Its market cap has increased by 4.63% in one year.

Market Cap
185.24M
Enterprise Value
135.46M
Revenue
20.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.01

Market Cap Chart

Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 185.24M, an increase of 23,284.82%. That is a compound annual growth rate of 34.21%.

History

DateMarket Cap% Change
May 12, 2025185.24M15.82%
Dec 31, 2024159.94M-24.29%
Dec 29, 2023211.24M-19.93%
Dec 30, 2022263.84M-24.98%
Dec 31, 2021351.67M28.64%
Dec 31, 2020273.37M-41.60%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition